Institut Mérieux

Institut Mérieux is contributing its experience in biology to improve medicine and public health across the globe. Its three bio-industrial companies (bioMérieux, Transgene and Mérieux NutriSciences), working alongside its entity devoted to investment in healthcare (Mérieux Equity Partners), have contributed to major advances in medicine and public health.

Key Figures

2.6%
OF GAV*
1.0bn
shareholding value
10.0%
economic rights
5.3%
voting rights

* As of 31 December 2025